179 related articles for article (PubMed ID: 20673016)
1. Plant-based vaccines against human hepatitis B virus.
Shchelkunov SN; Shchelkunova GA
Expert Rev Vaccines; 2010 Aug; 9(8):947-55. PubMed ID: 20673016
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus vaccines in plants.
Giorgi C; Franconi R; Rybicki EP
Expert Rev Vaccines; 2010 Aug; 9(8):913-24. PubMed ID: 20673013
[TBL] [Abstract][Full Text] [Related]
3. Production of hepatitis B surface antigen in recombinant plant systems: an update.
Kumar GB; Ganapathi TR; Bapat VA
Biotechnol Prog; 2007; 23(3):532-9. PubMed ID: 17348684
[TBL] [Abstract][Full Text] [Related]
4. Development of plant-based mucosal vaccines against widespread infectious diseases.
Salyaev RK; Rigano MM; Rekoslavskaya NI
Expert Rev Vaccines; 2010 Aug; 9(8):937-46. PubMed ID: 20673015
[TBL] [Abstract][Full Text] [Related]
5. Overview of expression of hepatitis B surface antigen in transgenic plants.
Guan ZJ; Guo B; Huo YL; Guan ZP; Wei YH
Vaccine; 2010 Oct; 28(46):7351-62. PubMed ID: 20850538
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form.
Smith ML; Mason HS; Shuler ML
Biotechnol Bioeng; 2002 Dec; 80(7):812-22. PubMed ID: 12402327
[TBL] [Abstract][Full Text] [Related]
7. Current status of plant-made vaccines for veterinary purposes.
Ling HY; Pelosi A; Walmsley AM
Expert Rev Vaccines; 2010 Aug; 9(8):971-82. PubMed ID: 20673018
[TBL] [Abstract][Full Text] [Related]
8. [Recombinant Oka varicella vaccine as a live hepatitis B virus vaccine].
Shiraki K; Takahara T
Nihon Rinsho; 1993 Jan; 51(1):241-7. PubMed ID: 8381884
[TBL] [Abstract][Full Text] [Related]
9. Plant glycans: friend or foe in vaccine development?
Bosch D; Schots A
Expert Rev Vaccines; 2010 Aug; 9(8):835-42. PubMed ID: 20673008
[TBL] [Abstract][Full Text] [Related]
10. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
[TBL] [Abstract][Full Text] [Related]
11. The ability of Hepatitis B surface antigen DNA vaccine to elicit cell-mediated immune responses, but not antibody responses, was affected by the deglysosylation of S antigen.
Xing Y; Huang Z; Lin Y; Li J; Chou TH; Lu S; Wang S
Vaccine; 2008 Sep; 26(40):5145-52. PubMed ID: 18462847
[TBL] [Abstract][Full Text] [Related]
12. Plant-derived vaccines and other therapeutics produced in contained systems.
Franconi R; Demurtas OC; Massa S
Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
[TBL] [Abstract][Full Text] [Related]
13. PharmaPlant: the new frontier in vaccines. Forward.
Buonaguro FM; Butler-Ransohoff JE
Expert Rev Vaccines; 2010 Aug; 9(8):805-7. PubMed ID: 20673004
[No Abstract] [Full Text] [Related]
14. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
[TBL] [Abstract][Full Text] [Related]
15. Western blot analysis of the reactivity between envelope proteins of hepatitis B viruses from Brazilian carriers and antibodies raised against recombinant hepatitis B vaccines.
De Castro L; Yoshida CF; Gaspar AM; Gomes SA
Acta Virol; 1996; 40(5-6):251-8. PubMed ID: 9171452
[TBL] [Abstract][Full Text] [Related]
16. [Construction of mucosal vaccine derived from HBV surface antigen epitope A and the assay of its immunogenicity].
Liu X; Yang G; Qiu B; Tian P
Wei Sheng Wu Xue Bao; 2001 Oct; 41(5):625-9. PubMed ID: 12552813
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 derived peptides fused to HBsAg affect its immunogenicity.
Gonzalez MC; Kostrzak A; Guetard D; Pniewski T; Sala M
Virus Res; 2009 Dec; 146(1-2):107-14. PubMed ID: 19766153
[TBL] [Abstract][Full Text] [Related]
18. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
[TBL] [Abstract][Full Text] [Related]
20. Host cell protein testing strategy for hepatitis B antigen in Hexavalent vaccine - Towards a general testing strategy for recombinant vaccines.
Toinon A; Fontaine C; Thion L; Gajewska B; Carpick B; Nougarede N; Uhlrich S
Biologicals; 2018 Jul; 54():1-7. PubMed ID: 29861269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
